drugset / Trial / NCT00109330
A Combined Tdap Vaccine Used As A Booster Compared To Licensed Td Vaccine
RandomizedParallel-groupSingle-blindPrevention
Summary
This study will evaluate the safety and immune response to GlaxoSmithKline Tdap vaccine compared to licensed Td vaccine when used as a booster in healthy adolescents (10-18 years of age).
Timeline
- Start
- 2002-11
- Primary completion
- 2004-04
- Completion
- 2004-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Combined diphtheria, tetanus, acellular pertussis vaccine | Vaccine | — | — |